InvestorsHub Logo
Followers 9
Posts 402
Boards Moderated 0
Alias Born 04/22/2013

Re: gestalt2 post# 18678

Thursday, 12/07/2017 8:31:49 PM

Thursday, December 07, 2017 8:31:49 PM

Post# of 233434
Gestalt:

First, plenty of fantastic dialogue & opinion on the board today.

Second, not sure why Fred used the term "us", he's not invested and peddles in fear, innuendo & fiction.

Third, and most important, I would encourage people to again listen to the final twelve minutes of the recent October conference call. Answers many questions about timelines and financing.

Without going into great detail both Pourhassan & Tony C. reiterated they believe the mono trial will finish enrollment by end of Q1 - They claim to have five possible avenues/options as to financing; 1) As needed, 2) Paulson, 3) Exercising of warrants, 4) Potential partners,5) Universal shelf registration

Pourhassan said more than once that 50 patients are required for efficacy, they have to wait to unblind the study after the 50 are enrolled and hoped that would be completed within eight weeks of the conference call. Tony C. reiterated these points as well.

My guess is they'll push the warrant exercise date back thirty days or so and continue to raise capital as needed. I viewed today's press release as positive news and bought more shares at .59cts-- Seems like a steal to me-





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News